OBJECTIVES: to estimate HIV-1 incidence and cofactors for HIV-1 incidence during pregnancy and postpartum. DESIGN: retrospective study among women who were HIV seronegative during pregnancy. METHODS: mothers accompanying their infants for routine 6-week immunizations at 6 maternal child health clinics in Nairobi and Western Kenya were tested for HIV-1 after completing a questionnaire that included assessment of sociodemographics, obstetric history and HIV-1 risk perception. RESULTS: of 2,135 mothers who had tested HIV-1 seronegative antenatally, 2,035 (95.3%) accepted HIV-1 re-testing at 6 weeks postpartum. Of these, 53 (2.6%) were HIV-1 seropositive yielding an estimated HIV-1 incidence of 6.8 (95% CI: 5.1-8.8) per 100 woman-years). Mothers who seroconverted were more likely to be employed (45.3% vs 29.0%, p=0.01), married (96.2 vs 86.6%, p=0.04) and from a higher HIV-1 prevalence region (60.4% in Western Kenya vs 28.8% in Nairobi, p<0.001). Among married women, those in polygamous relationship were significantly more likely to seroconvert (19.6% vs 6.7%, p<0.001). In multivariate analysis, region and employment independently predicted seroconversion. CONCLUSIONS: repeat HIV-1 testing in early postpartum was highly acceptable and resulted in detection of substantial HIV-1 incidence during pregnancy and postpartum period. Within prevention of mother-to-child HIV-1 transmission programs strategic approaches to prevent maternal HIV-1 acquisition during pregnancy are urgently needed.
OBJECTIVES: to estimate HIV-1 incidence and cofactors for HIV-1 incidence during pregnancy and postpartum. DESIGN: retrospective study among women who were HIV seronegative during pregnancy. METHODS: mothers accompanying their infants for routine 6-week immunizations at 6 maternal child health clinics in Nairobi and Western Kenya were tested for HIV-1 after completing a questionnaire that included assessment of sociodemographics, obstetric history and HIV-1 risk perception. RESULTS: of 2,135 mothers who had tested HIV-1 seronegative antenatally, 2,035 (95.3%) accepted HIV-1 re-testing at 6 weeks postpartum. Of these, 53 (2.6%) were HIV-1 seropositive yielding an estimated HIV-1 incidence of 6.8 (95% CI: 5.1-8.8) per 100 woman-years). Mothers who seroconverted were more likely to be employed (45.3% vs 29.0%, p=0.01), married (96.2 vs 86.6%, p=0.04) and from a higher HIV-1 prevalence region (60.4% in Western Kenya vs 28.8% in Nairobi, p<0.001). Among married women, those in polygamous relationship were significantly more likely to seroconvert (19.6% vs 6.7%, p<0.001). In multivariate analysis, region and employment independently predicted seroconversion. CONCLUSIONS: repeat HIV-1 testing in early postpartum was highly acceptable and resulted in detection of substantial HIV-1 incidence during pregnancy and postpartum period. Within prevention of mother-to-childHIV-1 transmission programs strategic approaches to prevent maternal HIV-1 acquisition during pregnancy are urgently needed.
Authors: T E Taha; G A Dallabetta; D R Hoover; J D Chiphangwi; L A Mtimavalye; G N Liomba; N I Kumwenda; P G Miotti Journal: AIDS Date: 1998-01-22 Impact factor: 4.177
Authors: Ronald H Gray; Xianbin Li; Godfrey Kigozi; David Serwadda; Heena Brahmbhatt; Fred Wabwire-Mangen; Fred Nalugoda; Mohamed Kiddugavu; Nelson Sewankambo; Thomas C Quinn; Steven J Reynolds; Maria J Wawer Journal: Lancet Date: 2005-10-01 Impact factor: 79.321
Authors: J M Baeten; B A Richardson; H L Martin; P M Nyange; L Lavreys; E N Ngugi; K Mandaliya; J O Ndinya-Achola; J J Bwayo; J K Kreiss Journal: J Acquir Immune Defic Syndr Date: 2000-08-15 Impact factor: 3.731
Authors: Stephanie L Sansom; Denise J Jamieson; Paul G Farnham; Marc Bulterys; Mary Glenn Fowler Journal: Obstet Gynecol Date: 2003-10 Impact factor: 7.661
Authors: Alison C Roxby; Jennifer A Unger; Jennifer A Slyker; John Kinuthia; Andrew Lewis; Grace John-Stewart; Judd L Walson Journal: Curr HIV/AIDS Rep Date: 2014-06 Impact factor: 5.071
Authors: Nora E Rosenberg; Lauren A Graybill; Austin Wesevich; Nuala McGrath; Carol E Golin; Suzanne Maman; Mercy Tsidya; Limbikani Chimndozi; Irving F Hoffman; Mina C Hosseinipour; William C Miller Journal: AIDS Behav Date: 2018-06
Authors: Alison C Roxby; Daniel Matemo; Alison L Drake; John Kinuthia; Grace C John-Stewart; Francisca Ongecha-Owuor; James Kiarie; Carey Farquhar Journal: AIDS Patient Care STDS Date: 2013-01 Impact factor: 5.078
Authors: John Kinuthia; Barbra A Richardson; Alison L Drake; Daniel Matemo; Jennifer A Unger; Raymond S McClelland; Grace John-Stewart Journal: J Acquir Immune Defic Syndr Date: 2017-02-01 Impact factor: 3.731
Authors: John Kinuthia; Alison L Drake; Daniel Matemo; Barbra A Richardson; Clement Zeh; Lusi Osborn; Julie Overbaugh; R Scott McClelland; Grace John-Stewart Journal: AIDS Date: 2015-09-24 Impact factor: 4.177